DK0873134T3 - Langvarig frigørelsesformulering omfattende bovin væksthormon frigørende faktor - Google Patents

Langvarig frigørelsesformulering omfattende bovin væksthormon frigørende faktor

Info

Publication number
DK0873134T3
DK0873134T3 DK96945382T DK96945382T DK0873134T3 DK 0873134 T3 DK0873134 T3 DK 0873134T3 DK 96945382 T DK96945382 T DK 96945382T DK 96945382 T DK96945382 T DK 96945382T DK 0873134 T3 DK0873134 T3 DK 0873134T3
Authority
DK
Denmark
Prior art keywords
growth hormone
hormone releasing
releasing factor
release formulation
bovine growth
Prior art date
Application number
DK96945382T
Other languages
English (en)
Inventor
Todd P Foster
William M Moseley
James F Caputo
Michael J Hageman
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0873134T3 publication Critical patent/DK0873134T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF] (Somatoliberin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
DK96945382T 1996-01-11 1996-12-13 Langvarig frigørelsesformulering omfattende bovin væksthormon frigørende faktor DK0873134T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US973896P 1996-01-11 1996-01-11
PCT/US1996/019417 WO1997025057A1 (en) 1996-01-11 1996-12-13 Aqueous prolonged release formulation

Publications (1)

Publication Number Publication Date
DK0873134T3 true DK0873134T3 (da) 2003-08-11

Family

ID=21739423

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96945382T DK0873134T3 (da) 1996-01-11 1996-12-13 Langvarig frigørelsesformulering omfattende bovin væksthormon frigørende faktor

Country Status (14)

Country Link
US (2) US6150330A (da)
EP (1) EP0873134B1 (da)
JP (1) JP2000506509A (da)
KR (1) KR100445087B1 (da)
CN (1) CN1130222C (da)
AT (1) ATE238063T1 (da)
CA (1) CA2240685A1 (da)
DE (1) DE69627706T2 (da)
DK (1) DK0873134T3 (da)
ES (1) ES2197258T3 (da)
HK (1) HK1016083A1 (da)
NZ (1) NZ326953A (da)
PT (1) PT873134E (da)
WO (1) WO1997025057A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100445087B1 (ko) * 1996-01-11 2004-10-15 파마시아 앤드 업존 캄파니 수성서방성제제
AU2002233082B2 (en) * 2001-02-02 2005-11-10 Conjuchem Biotechnologies Inc. Long lasting growth hormone releasing factor derivatives
NZ539218A (en) * 2002-09-18 2008-03-28 Univ Montreal Ct Hospitalier Chum Synthetic GHRH analogues of 29 amino acids or more
US8871713B2 (en) 2013-03-01 2014-10-28 Theratechnologies Inc. Formulations of growth hormone releasing factor (GRF) molecules with improved stability
US9119832B2 (en) 2014-02-05 2015-09-01 The Regents Of The University Of California Methods of treating mild brain injury
US20170121385A1 (en) 2015-10-28 2017-05-04 Oxeia Biopharmaceuticals, Inc. Methods of treating neurodegenerative conditions
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196714B (en) * 1984-10-04 1989-01-30 Monsanto Co Process for producing non-aqueous composition comprising somatotropin
US4977140A (en) * 1985-08-23 1990-12-11 Eli Lilly And Company Injectable sustained release formulation
US5756458A (en) * 1989-06-16 1998-05-26 Pharmacia & Upjohn Company Stabilized potent GRF analogs
DE69014115T2 (de) * 1989-06-16 1995-05-24 Upjohn Co Stabilisierte, starke grf-analoga.
JPH06500311A (ja) * 1990-06-29 1994-01-13 エフ・ホフマン―ラ　ロシュ　アーゲー ヒスチジン置換されたヒト成長ホルモン放出因子類縁体
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
DE69312947T2 (de) * 1992-09-21 1998-01-08 Pharmacia & Upjohn Company Kal Proteinhaftige arzneimittel mit verzögerter wirkstoffabgabe
ZA949350B (en) * 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
KR100445087B1 (ko) * 1996-01-11 2004-10-15 파마시아 앤드 업존 캄파니 수성서방성제제

Also Published As

Publication number Publication date
CN1130222C (zh) 2003-12-10
DE69627706T2 (de) 2004-02-05
KR100445087B1 (ko) 2004-10-15
US6429195B1 (en) 2002-08-06
JP2000506509A (ja) 2000-05-30
ATE238063T1 (de) 2003-05-15
CN1202114A (zh) 1998-12-16
EP0873134A1 (en) 1998-10-28
AU1564997A (en) 1997-08-01
NZ326953A (en) 2001-03-30
WO1997025057A1 (en) 1997-07-17
CA2240685A1 (en) 1997-07-17
US6150330A (en) 2000-11-21
PT873134E (pt) 2003-08-29
AU705466B2 (en) 1999-05-20
KR19990077154A (ko) 1999-10-25
HK1016083A1 (en) 1999-10-29
DE69627706D1 (de) 2003-05-28
ES2197258T3 (es) 2004-01-01
EP0873134B1 (en) 2003-04-23

Similar Documents

Publication Publication Date Title
ES2526707T3 (es) Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
DE69434418D1 (de) Orale Dareichungsform
ES2090714T3 (es) Matriz de vidrio de carbohidrato para la liberacion prolongada de un agente terapeutico.
MY125556A (en) Aqueous formulations of peptide
DE69434963D1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
DK336986D0 (da) Fremgangsmaade til fremstilling af toerre biologisk aktive rekombinante vaeksthormoner
AR040527A1 (es) Formulaciones de hgh en alta concentracion que contienen glicina
RU98117135A (ru) Композиция стабилизированного гормона роста и способ ее приготовления
ES2114851T3 (es) Utilizacion de composiciones de liberacion sostenida que contienen gnrh, lhrh o derivados de las mismas.
CA2246501A1 (en) Stabilised growth hormone formulation and method of preparation thereof
DK0873134T3 (da) Langvarig frigørelsesformulering omfattende bovin væksthormon frigørende faktor
DE69513635T2 (de) Wässrige zubereitung mit verzögerter wirkstofffreigabe
GB8603964D0 (en) Compositions
GR3029319T3 (en) Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity
WO1998029131A3 (en) Aqueous glycerol formulations of somatotropin
IL110888A (en) Pharmaceutical compositions for the treatment of liver diseases comprising a vasodilating compound
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.
RU94020413A (ru) Способ осеменения животных